Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

2.

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.

Josting A, Wiedenmann S, Franklin J, May M, Sieber M, Wolf J, Engert A, Diehl V; German Hodgkin's Lymphoma Study Group.

J Clin Oncol. 2003 Sep 15;21(18):3440-6. Epub 2003 Mar 7.

PMID:
12668650
3.
4.

Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation.

Pedersen-Bjergaard J, Andersen MK, Christiansen DH.

Blood. 2000 Jun 1;95(11):3273-9. Review. Erratum in: Blood 2000 Sep 1;96(5):1680.

5.

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.

Harrison CN, Gregory W, Hudson GV, Devereux S, Goldstone AH, Hancock B, Winfield D, MacMillan AK, Hoskin P, Newland AC, Milligan D, Linch DC.

Br J Cancer. 1999 Oct;81(3):476-83.

6.

Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.

Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Andresen S, Kuczkowski E, Bolwell B.

J Clin Oncol. 2006 Aug 1;24(22):3604-10.

PMID:
16877727
7.
8.

Autologous bone marrow transplantation for patients with myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS. Chronic and Acute Leukemia Working Parties of the European Group for Blood and Marrow Transplantation.

De Witte T, Van Biezen A, Hermans J, Labopin M, Runde V, Or R, Meloni G, Mauri SB, Carella A, Apperley J, Gratwohl A, Laporte JP.

Blood. 1997 Nov 15;90(10):3853-7.

9.
10.

Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation.

Sevilla J, Rodríguez A, Hernández-Maraver D, de Bustos G, Aguado J, Ojeda E, Arrieta R, Hernández-Navarro F.

Ann Hematol. 2002 Jan;81(1):11-5. Epub 2001 Dec 8.

PMID:
11807629
12.

Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy.

Miller JS, Arthur DC, Litz CE, Neglia JP, Miller WJ, Weisdorf DJ.

Blood. 1994 Jun 15;83(12):3780-6.

13.

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ.

Blood. 2003 Mar 1;101(5):2015-23. Epub 2002 Oct 10.

14.

The in vitro detection of anti-leukaemia-specific cytotoxicity after autologous bone marrow transplantation for acute leukaemia.

Lowdell MW, Ray N, Craston R, Corbett T, Deane M, Prentice HG.

Bone Marrow Transplant. 1997 May;19(9):891-7.

15.

Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma.

Legare RD, Gribben JG, Maragh M, Hermanowski-Vosatka A, Roach S, Tantravahi R, Nadler LM, Gilliland DG.

Am J Hematol. 1997 Sep;56(1):45-51.

16.

Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation.

Del Cañizo Mf, Amigo Mf, Hernández JM, Sanz G, Núñez R, Carreras E, Alegre A, Cuesta B, Mataix R.

Haematologica. 2000 Apr;85(4):403-9.

17.

Transformation of myelodysplastic syndromes into acute myeloid leukemias.

Shi J, Shao ZH, Liu H, Bai J, Cao YR, He GS, Tu MF, Wang XL, Hao YS, Yang TY, Yang CL.

Chin Med J (Engl). 2004 Jul;117(7):963-7.

PMID:
15265365
18.

Acute myeloid leukemia and myelodysplasia following intensive chemotherapy for breast cancer.

Roman-Unfer S, Bitran JD, Hanauer S, Johnson L, Rita D, Booth C, Chen K.

Bone Marrow Transplant. 1995 Jul;16(1):163-8.

PMID:
7581117
19.

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA.

Blood. 2003 Jul 1;102(1):43-52. Epub 2003 Mar 6.

20.

Chromosomal abnormalities in women with breast cancer after autologous stem cell transplantation are infrequent and may not predict development of therapy-related leukemia or myelodysplastic syndrome.

Martínez-Climent JA, Comes AM, Vizcarra E, Benet I, Arbona C, Prósper F, Solano C, García Clavel B, Marugán I, Lluch A, García-Conde J.

Bone Marrow Transplant. 2000 Jun;25(11):1203-8.

Supplemental Content

Support Center